November 13, 2007 – ImaRx Therapeutics Inc. and Philips will collaborate to evaluate Philips ultrasound technology as part of ImaRx’s SonoLysis program to develop new treatment for acute ischemic stroke, in order to determine the optimal ultrasound parameters to use with ImaRx’s proprietary MRX-801 microbubble technology.
Under the agreement, Philips’ Medical Systems division will provide ultrasound devices and technical assistance to ImaRx during laboratory and preclinical studies.
The agreement includes a mutual exclusivity clause during the term of the collaboration. Following completion of the research program, Philips and ImaRx will have an exclusive negotiation period to discuss future development and commercialization.
For more information: www.medical.philips.com